Condition: XIAP Deficiency · Sponsor: Children's Hospital Medical Center, Cincinnati
The purpose of the study is to evaluate safety and tolerability of oral quercetin in reducing inflammation in male patients with XIAP deficiency. Quercetin is a naturally occurring antioxidant that has many properties including the ability to decrease inflammation in other diseases.
This description comes directly from the study's public registry record.
Kelly McIntosh · 513-803-0460 · Kelly.mcintosh@cchmc.org
Richard Cooper · 513-803-7450 · richard.cooper@cchmc.org
Always discuss trial participation with your own doctor first.
| Cincinnati Children's Hospital Medical Center | Cincinnati, Ohio, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07433621